drug protocol number

CA2390004

drug sponsor

Bristol-Myers Squibb Company / Balsam CRO

drug study

Adagrasib(BMS-986503/KRAZATI®)

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase